skip to Main Content
Apr 01 2018

Correction of Anemia with Epoetin Alfa

EBM, Landmark Research

Anemia is a common complication of chronic kidney disease which is typically treated with recombinant human erythropoietin. However the ideal goal hemoglobin is not well established. This study looks to answer if a lower-goal hemoglobin CKD patients shows decreased adverse…

Read more
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.